Synthetic routes and lipase-inhibiting activity of long-chain α-keto amides

被引:23
作者
Chiou, A
Verger, R
Kokotos, G [1 ]
机构
[1] Univ Athens, Dept Chem, Organ Chem Lab, GR-15771 Athens, Greece
[2] CNRS, UPR 9025, Lab Lipolyse Enzymat, F-13402 Marseille, France
关键词
D O I
10.1007/s11745-001-0754-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Synthetic routes to primary and N-alkyl alpha -keto amides are presented in this paper. Primary alpha -keto amides may be prepared by using an aldehyde as starting material. Commercially available alpha -keto acids may be coupled in high yield with primary amines by the mixed carbonic anhydride method affording N-alkyl alpha -keto amides. Alternatively, N-alkyl alpha -keto amides may be prepared by coupling long-chain alpha -hydroxy acids with amino components, followed by oxidation with pyridinium dichromate or NaOCl in the presence of 4-acetamido-2,2,6,6-tetramethyl-1-piperidinyloxy free radical. The alpha -keto amide derivatives prepared according to these procedures were tested for their ability to form stable monomolecular films at the air/water interface. The inhibition of porcine pancreatic lipase by the alpha -keto amides, spread as mixed films with 1,2-dicaprin, was studied with the monolayer technique. Among the compounds tested in this study, methyl 2-[(2-ketododecanoyl)amino]hexadecanoate was shown to be the most potent inhibitor, causing a 50% decrease in lipase activity at a 0.09 molar fraction.
引用
收藏
页码:535 / 542
页数:8
相关论文
共 35 条
[1]   INHIBITION OF MACROPHAGE CA2+-INDEPENDENT PHOSPHOLIPASE A(2) BY BROMOENOL LACTONE AND TRIFLUOROMETHYL KETONES [J].
ACKERMANN, EJ ;
CONDEFRIEBOES, K ;
DENNIS, EA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (01) :445-450
[2]   A REINVESTIGATION OF MIXED CARBONIC ANHYDRIDE METHOD OF PEPTIDE SYNTHESIS [J].
ANDERSON, GW ;
ZIMMERMAN, JE ;
CALLAHAN, FM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1967, 89 (19) :5012-+
[3]  
Bjorkling F, 1994, Bioorg Med Chem, V2, P697, DOI 10.1016/0968-0896(94)85020-8
[4]   Inhibition of human gastric and pancreatic lipases by chiral alkylphosphonates.: A kinetic study with 1,2-didecanoyl-sn-glycerol monolayer [J].
Cavalier, JF ;
Ransac, S ;
Verger, R ;
Buono, G .
CHEMISTRY AND PHYSICS OF LIPIDS, 1999, 100 (1-2) :3-31
[5]   Synthesis and study of a lipophilic α-keto amide inhibitor of pancreatic lipase [J].
Chiou, A ;
Markidis, T ;
Constantinou-Kokotou, V ;
Verger, R ;
Kokotos, G .
ORGANIC LETTERS, 2000, 2 (03) :347-350
[6]   Activated ketones as inhibitors of intracellular Ca2+-dependent and Ca2+-independent phospholipase A(2) [J].
CondeFrieboes, K ;
Reynolds, LJ ;
Lio, YC ;
Hale, MR ;
Wasserman, HH ;
Dennis, EA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (24) :5519-5525
[7]   A STRUCTURAL BASIS FOR THE CHIRAL PREFERENCES OF LIPASES [J].
CYGLER, M ;
GROCHULSKI, P ;
KAZLAUSKAS, RJ ;
SCHRAG, JD ;
BOUTHILLIER, F ;
RUBIN, B ;
SERREQI, AN ;
GUPTA, AK .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1994, 116 (08) :3180-3186
[8]  
DRENT ML, 1995, INT J OBESITY, V19, P221
[9]   THE 2.46-ANGSTROM RESOLUTION STRUCTURE OF THE PANCREATIC LIPASE-COLIPASE COMPLEX INHIBITED BY A C-11 ALKYL PHOSPHONATE [J].
EGLOFF, MP ;
MARGUET, F ;
BUONO, G ;
VERGER, R ;
CAMBILLAU, C ;
VANTILBEURGH, H .
BIOCHEMISTRY, 1995, 34 (09) :2751-2762
[10]   One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor [J].
Finer, N ;
James, WPT ;
Kopelman, PG ;
Lean, MEJ ;
Williams, G .
INTERNATIONAL JOURNAL OF OBESITY, 2000, 24 (03) :306-313